课题基金 / 基金详情

GLIAL REACTION TO ISCHEMIC BRAIN INJURY

GLIAL REACTION TO ISCHEMIC BRAIN INJURY
神经胶质对缺血性脑损伤的反应
批准号:
6126094
负责人:
Richard P Kraig
金额:
$27.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-04-01 至 2003-11-30

项目摘要

项目成果

Richard P Kraig的其他基金

相似基金

相关文献

中文摘要
翻译
缺血性脑损伤是死亡和残疾的主要原因,很少见 有效的治疗方法。扩散性抑郁(SD)可加重脑损伤 如果它发生在缺血前不到一天。然而,SD也可以 如果发生在缺血前1-3天,即所谓的缺血,则减少损伤 宽容。因此,神经细胞和组织具有内源性能力。 来调节自己受伤的程度。SD本身是无害的。 此外,它在与SD相同的时间段内诱导星形胶质细胞增生症- 诱导缺血耐受。由于胶质细胞激活神经元,SD诱导 胶质细胞增多症可能是SD发展所需的关键转化。 诱导对缺血损伤的耐受。因此,总的目标是 本提案是为了定义基本的信令机制 负责SD,因此开始定义所需的基本触发器 SD诱导的胶质细胞增生和SD诱导的对兴奋性毒性损伤的耐受。 实验将系统地结合体外创新的 用现代调查工具准备探索基础 SID的生理和解剖改变。海马器官培养 (HOTC)将在整个项目中使用,因为:(A)HOTC是 一个完整的脑组织区域,维持许多细胞间的联系 体内发现关系,但HOTCs在体外存活数月;(B) 高含氧化合物的微环境条件易于控制;(C) Hotc内的单个小区可以在空间和时间上跟踪;(D) 我们已经证明HOTCs支持SD并发展为星形胶质细胞增生症 在活体内看到的。因此,SD、SD诱导的胶质细胞增生症和SD诱导的耐受 它们需要几天的时间才能进化,现在可以在 体外培养。这意味着,易于访问和 体外制剂的微环境控制可应用于 在细胞和分子水平上回答“机械性”问题 需要完整组织的赛事。膜片钳技术,计算机- 将使用基于成像策略和分子生物学技术 实现以下具体目标。(1)审查 缝隙连接功能变化的时空动力学研究 神经元之间以及与SD相关的星形胶质细胞之间。(2)审查 SD诱发电流的时空变化及其同一性 海马区锥体细胞。(3)研究细胞和细胞因子的作用机制。 SD大鼠肾间质钙离子的变化。(4)研究钙离子或钙离子的调节 SD的酸碱变化影响SD诱导的胶质细胞增厚及对 兴奋性中毒性损伤。
英文摘要
Ischemic brain injury is a major cause of death and disability with few effective treatments. Spreading depression (SD) can enhance brain injury if it occurs less than a day before ischemia. However, SD also can reduce injury if it occurs 1-3 days before ischemia, so-called ischemic tolerance. Thus, neural cells and tissues have an endogenous ability to modulate the extent of their own injury. SD itself is noninjurious. Furthermore it induces astrogliosis over the same time period as SD- induced ischemic tolerance. Since glia vitalize neurons, SD-induced gliosis may be a key transformation needed for the development of SD- induced tolerance to ischemic injury. Accordingly, the general goal of this proposal is to define the fundamental signaling mechanisms responsible for SD and so begin to define the basic triggers needed for SD-induced gliosis and SD-induced tolerance to excitotoxic injury. Experiments will systematically combine an innovative in vitro preparation with modern investigative tools to explore fundamental physiologic and anatomic changes of SID. Hippocampal organ cultures (HOTCs) will be used throughout this project because: (A) the HOTC is an intact area of brain tissue that maintains many cell-to-cell relationships found in vivo yet HOTCs survive in vitro for months; (B) microenvironmental conditions of HOTCs can be easily controlled; (C) individual cells within the HOTC can be followed in space and time; (D) we have shown that HOTCs support SD and develop astrogliosis like that seen in vivo. Thus, SD, SD-induced gliosis and SD-induced tolerance which require days to evolve, can now be examined for the first time in vitro. This means that the experimental advantages of easy access and microenvironmental control of in vitro preparations can be applied to answer 'mechanistic' questions at the cellular and molecular level of events that require intact tissues. Patch clamp technology, computer- based imaging strategies, and molecular biologic techniques will be used to accomplish the following specific aims. (1) Examine the spatiotemporal dynamics of gap junction functional changes between neurons and between astrocytes associated with SD. (2) Examine the spatiotemporal changes and identity of SD-induced currents in hippocampal pyramidal cells. (3) Examine the mechanisms of cellular and interstitial Ca2+ changes of SD. (4) Examine how modulation of Ca2+ or acid-base changes of SD influence SD-induced gliosis and tolerance to excitotoxic injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exosome RNA-Therapeutics to Promote CNS Myelination
  • 批准号:
    8811811
  • 项目类别:
  • 资助金额:
    $7.9万
  • 财政年份:
    2013
  • 负责人:
    Richard P Kraig
  • 依托单位:
Exosome RNA-Therapeutics to Promote CNS Myelination
  • 批准号:
    9128775
  • 项目类别:
  • 资助金额:
    $32.35万
  • 财政年份:
    2013
  • 负责人:
    Richard P Kraig
  • 依托单位:
Exosome RNA-Therapeutics to Promote CNS Myelination
  • 批准号:
    9060634
  • 项目类别:
  • 资助金额:
    $7.9万
  • 财政年份:
    2013
  • 负责人:
    Richard P Kraig
  • 依托单位:
Exosome RNA-Therapeutics to Promote CNS Myelination
  • 批准号:
    8708236
  • 项目类别:
  • 资助金额:
    $24.02万
  • 财政年份:
    2013
  • 负责人:
    Richard P Kraig
  • 依托单位:
国内基金
海外基金
Ascl1介导Wnt/beta-catenin通路在TLE海马硬化中反应性Astrocytes异常增生的作用及调控机制
  • 批准号:
    31760279
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2017
  • 负责人:
    丁银秀
  • 依托单位: